Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 8/2016

01-08-2016 | Clinical Investigation

Mechanism and Natural Course of Tumor Involution in Hepatocellular Carcinoma Following Transarterial Ethanol Ablation

Authors: Simon Chun Ho Yu, Tiffany Wing Wa Lau, Peggy Tang, Stephen Ka Chi Chan, Charmant Cheuk Man Chu, Joyce Wai Yi Hui, Kit Fai Lee, Anthony Chan

Published in: CardioVascular and Interventional Radiology | Issue 8/2016

Login to get access

Abstract

Purpose

To evaluate the microvascular distribution of lipiodol–ethanol, the histological change of the tumor lesion, and the status of tumor involution over time in hepatocellular carcinoma (HCC) following transarterial ethanol ablation (TEA), in lesions that showed CT evidence of complete tumor response.

Materials and methods

Patients with unresectable HCC were treated (183 patients, 242 lesions) with TEA using lipiodol–ethanol mixture (LEM) mixed in 2:1 ratio by volume and followed with CT at 3-month intervals for a median of 14.1 months. Liver tumors (n = 131) that showed CT evidence of complete tumor response, defined as the absence of any enhancing tumor throughout the follow-up period, were included. The surgical specimens of five patients who subsequently received partial hepatectomy were available for histological assessment. The microvascular distribution of LEM and the degree of tumor necrosis were analyzed. Tumor involution over time was assessed with CT in lesions that showed complete response.

Results

Lipid stain revealed lipiodol infiltration throughout arterioles, intratumoral sinusoidal spaces, tumor capsule, and peritumoral portal venules. Complete tumor necrosis (100 %) occurred in all 5 surgical specimens. The median (IQR) percentage tumor volume compared to baseline volumes at 12, 36, and 60 months was 32 % (23.5–52.5 %), 22 % (8–31 %), and 13.5 % (6–21.5 %), respectively.

Conclusion

Intrahepatic HCC lesion that showed CT evidence of complete tumor response following TEA is associated with histological evidence of LEM infiltration throughout the intratumoral and peritumoral vasculature and complete tumor necrosis, as well as sustained reduction in tumor volume over time.
Literature
1.
go back to reference Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat data- base: incidence—SEER 9 Regs research data, Nov 2009 Sub (1973–2007). Bethesda, MD: National Cancer Institute, April 2010. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat data- base: incidence—SEER 9 Regs research data, Nov 2009 Sub (1973–2007). Bethesda, MD: National Cancer Institute, April 2010.
3.
go back to reference Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mor- tality and prevalence worldwide, version 1.0. International Agency for Research on Cancer CancerBase no. 5. Lyon, France: IARC Press; 2001. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mor- tality and prevalence worldwide, version 1.0. International Agency for Research on Cancer CancerBase no. 5. Lyon, France: IARC Press; 2001.
4.
5.
go back to reference Maluccio MA, Covey AM, Porat LB, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2008;19(6):862–9 Epub 2008 Apr 10.CrossRefPubMed Maluccio MA, Covey AM, Porat LB, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2008;19(6):862–9 Epub 2008 Apr 10.CrossRefPubMed
6.
go back to reference Sato KT, Lewandowski RJ, Mulcahy MF, et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres—safety, efficacy and survival. Radiology. 2008;247(2):507–15.CrossRefPubMed Sato KT, Lewandowski RJ, Mulcahy MF, et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres—safety, efficacy and survival. Radiology. 2008;247(2):507–15.CrossRefPubMed
7.
go back to reference Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardio- Vasc Interv Radiol. 2010;33(1):41–52.CrossRef Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardio- Vasc Interv Radiol. 2010;33(1):41–52.CrossRef
8.
go back to reference Cheng Y, Kan Z, Chen C, et al. Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg. 2000;24(7):844–50.CrossRefPubMed Cheng Y, Kan Z, Chen C, et al. Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg. 2000;24(7):844–50.CrossRefPubMed
9.
go back to reference Cheung YC, Ko SF, Ng SH, Chan SC, Cheng YF. Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma. World J Gastroenterol. 2005;11(18):2792–5.CrossRefPubMedPubMedCentral Cheung YC, Ko SF, Ng SH, Chan SC, Cheng YF. Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma. World J Gastroenterol. 2005;11(18):2792–5.CrossRefPubMedPubMedCentral
10.
go back to reference Yu SCH, Hui EP, Wong J, et al. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol-ethanol mixture: phase II Study. J Vasc Interv Radiol. 2008;19(1):95–103.CrossRefPubMed Yu SCH, Hui EP, Wong J, et al. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol-ethanol mixture: phase II Study. J Vasc Interv Radiol. 2008;19(1):95–103.CrossRefPubMed
11.
go back to reference Yu SCH, Hui JWY, Hui EP, et al. Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2009;20:352–9.CrossRefPubMed Yu SCH, Hui JWY, Hui EP, et al. Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2009;20:352–9.CrossRefPubMed
12.
go back to reference Yu SC, Hui JW, Hui EP, et al. Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization. Radiology. 2014;270(2):607–20.CrossRefPubMed Yu SC, Hui JW, Hui EP, et al. Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization. Radiology. 2014;270(2):607–20.CrossRefPubMed
13.
go back to reference Kan Z, Ivancev K, Lunderquist A. Peribiliary plexa-important pathways for shunting of iodized oil and silicon rubber solution from the hepatic artery to the portal vein: an experimental study in rats. Investig Radiol. 1994;29(7):671–6.CrossRef Kan Z, Ivancev K, Lunderquist A. Peribiliary plexa-important pathways for shunting of iodized oil and silicon rubber solution from the hepatic artery to the portal vein: an experimental study in rats. Investig Radiol. 1994;29(7):671–6.CrossRef
14.
go back to reference Kan Z, Wallace S. Transcatheter liver lobar ablation: an experimental trial in an animal model. Eur Radiol. 1997;7(7):1071–5.CrossRefPubMed Kan Z, Wallace S. Transcatheter liver lobar ablation: an experimental trial in an animal model. Eur Radiol. 1997;7(7):1071–5.CrossRefPubMed
15.
go back to reference Yu SCH, Chan CTP. Transarterial ethanol ablation of cirrhotic liver with lipiodol-ethanol mixture: safety and efficacy study in rats. Investig Radiol. 2006;41(8):609–17.CrossRef Yu SCH, Chan CTP. Transarterial ethanol ablation of cirrhotic liver with lipiodol-ethanol mixture: safety and efficacy study in rats. Investig Radiol. 2006;41(8):609–17.CrossRef
Metadata
Title
Mechanism and Natural Course of Tumor Involution in Hepatocellular Carcinoma Following Transarterial Ethanol Ablation
Authors
Simon Chun Ho Yu
Tiffany Wing Wa Lau
Peggy Tang
Stephen Ka Chi Chan
Charmant Cheuk Man Chu
Joyce Wai Yi Hui
Kit Fai Lee
Anthony Chan
Publication date
01-08-2016
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 8/2016
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-016-1360-z

Other articles of this Issue 8/2016

CardioVascular and Interventional Radiology 8/2016 Go to the issue